Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001956827-24-000013
Filing Date
2024-09-09
Accepted
2024-09-09 16:05:29
Documents
2
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 6-K a6-kenglishq22024.htm 6-K 2997282
2 EX-99.1 item991-pressrelease.htm EX-99.1 51652
  Complete submission text file 0001956827-24-000013.txt   3049928
Mailing Address 7 BD HAUSSMANN PARIS I0 75009
Business Address 7 BD HAUSSMANN PARIS I0 75009 01 53 83 09 63
Abivax S.A. (Filer) CIK: 0001956827 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41842 | Film No.: 241287276
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)